Wingtech Pharmaceutical
Suzhou
About Wingtech Pharmaceutical
Wingtech Pharmaceuticals is an innovative pharmaceutical company that develop drugs for the treatment of chronic metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2024)
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/wingtech-pharmaceutical-113941 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.